Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII

E-ISSN： 1875-533x|17|15|1516-1526

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.15, 2010-05, pp. : 1516-1526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbonic Anhydrase Activation and the Drug Design

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 708-715

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling and 3D QSAR Studies of Novel Human Carbonic Anhydrase IX Inhibitors

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-11 ,pp. : 808-816

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3233-3245

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs

Current Medicinal Chemistry, Vol. 19, Iss. 6, 2012-02 ,pp. : 821-830

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3246-3254

Bentham Science Publishers

Access to resources Recommend Favorite